Search

everythinglearnresearchcommunity

for

Search:↓

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Azelaic acid in a special gel is more effective against skin fungi than regular azelaic acid.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.

Axitinib treatment turned a man's grey hair back to black.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.